Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 81 ~ 100 of 2699, Page 5 of 136
81. Medtronic Enrolls First Patient in Clinical Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery
Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids
01/17/2019 Medtronic
82. Japanese Red Cross Society Selects Abbott Technology to Screen Country''s Blood and Plasma Supply
LONG-TERM AGREEMENT BETWEEN JAPANESE RED CROSS SOCIETY AND ABBOTT BRINGS TOGETHER TWO GLOBAL LEADERS IN BLOOD AND PLASMA SCREENING, HELPING ENSURE A SAFE AND EFFICIENT BLOOD SUPPLY ACROSS JAPAN
01/17/2019 Abbott
83. Abbott To Acquire Cephea Valve Technologies, Inc.
Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment
01/16/2019 Abbott
84. Statement from FDA Commissioner, Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies
01/15/2019 U.S. FOOD & DRUG ADMINISTRATION
85. Medtronic Launches Mobile App That Communicates Directly with World''s First Smartphone-Connected Pacemakers
MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics
01/15/2019 Medtronic
86. FDA Approves World''s First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect)
First and only minimally invasive, transcatheter treatment specifically approved for premature babies with a patent ductus, a life-threatening opening in their heart
01/14/2019 Abbott
87. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s new actions under the Pre-Cert Pilot Program to promote a more efficient framework for the review of safe and effective digital health innovations
01/07/2019 U.S. FOOD & DRUG ADMINISTRATION
88. New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health
IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance
01/03/2019 Medtronic
89. FDA permits marketing of a diagnostic test to aid in measuring nutrients in breast milk
Miris Human Milk Analyzer, a new diagnostic test to aid healthcare professionals in measuring nutrients in breast milk, including the concentration of fat, carbohydrate, protein, total solids and energy
12/21/2018 U.S. FOOD & DRUG ADMINISTRATION
90. Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales
FDA continues to evaluate the product’s long-term safety profile past its scheduled discontinuation from the U.S. market following a series of earlier regulatory actions that we took apply significant new requirements on its use. This includes the agency’s decision to take the step of making Essure a restricted device
12/20/2018 U.S. FOOD & DRUG ADMINISTRATION
91. Medtronic Completes Acquisition of Mazor Robotics
Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and Transform Outcomes for Hospitals, Surgeons, and Patients
12/19/2018 Medtronic
92. Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety
12/18/2018 U.S. FOOD & DRUG ADMINISTRATION
93. FDA Approves Smart Programmer for the InterStim System
Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
12/17/2018 Medtronic
94. Merck to Acquire Privately Held Antelliq Group
Establishes Merck Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology / Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals
12/14/2018 MERCK
95. Novel Technique May Significantly Reduce Breast Biopsies
A combination of three-compartment breast image analysis and radiomics may improve cancer diagnosis and reduce breast biopsies...
12/11/2018 Radiological Society of North America
96. Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework
12/11/2018 U.S. FOOD & DRUG ADMINISTRATION
97. Digital Mammography Increases Breast Cancer Detection
Digital mammography increased cancer detection by an overall rate of 14 percent in a large UK study...
12/11/2018 Radiological Society of North America
98. Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new effort for developing and class labeling of in vitro companion diagnostics for classes of oncology therapeutic products
One challenge we face right now, when it comes to developing diagnostics that can help target the delivery of cancer drugs, is the way these diagnostics are sometimes labeled.
12/06/2018 U.S. FOOD & DRUG ADMINISTRATION
99. Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new strategic framework to advance use of real-world evidence to support development of drugs and biologics
12/06/2018 U.S. FOOD & DRUG ADMINISTRATION
100. FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
12/04/2018 U.S. FOOD & DRUG ADMINISTRATION
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱